The most appropriate method to protect osteoporosis is to start the patient with either Denozumab or zolendronic acid. However, it is important to see risk vs benefit. Treatment, dosage, duration, drug holidays will vary from patient to patient and according to side effect profile. Therefore, follow up and proper investigation is important.